Search research articles
Contact Us
Filters
Showing results (921-930 of 993) with videos related to
Page
of 100
Sort By:
European Urology
|
October 29, 2015
Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies
Joaquim Bellmunt, Thian Kheoh, Margaret K Yu, et al.
JCO Precision Oncology
|
January 31, 2025
Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer
Felix Y Feng, Matthew R Smith, Fred Saad, et al.
World Journal of Urology
|
May 22, 2024
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients
Simone Morra, Reha-Baris Incesu, Lukas Scheipner, et al.
Urologic Oncology
|
September 6, 2025
Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinoma
Natali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
Susan Halabi, Qian Yang, Akash Roy, et al.
European Urology Focus
|
March 11, 2023
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm
Stefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Cancers
|
April 14, 2025
Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in Quadragenarians
Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Maha Hussain, Claire Corcoran, Caroline Sibilla, et al.
European Urology
|
January 18, 2025
Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis
Silke Gillessen, Bertrand Tombal, Fabio Turco, et al.
JAMA Surgery
|
October 2, 2024
Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial
Rodney H Breau, Luke T Lavallée, Ilias Cagiannos, et al.
Page
of 100
Search research articles
Search
Showing results (921-930 of 993) with videos related to
Sort By:
Page
of 100
European Urology
|
October 29, 2015
Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies
Joaquim Bellmunt, Thian Kheoh, Margaret K Yu, et al.
JCO Precision Oncology
|
January 31, 2025
Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer
Felix Y Feng, Matthew R Smith, Fred Saad, et al.
World Journal of Urology
|
May 22, 2024
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients
Simone Morra, Reha-Baris Incesu, Lukas Scheipner, et al.
Urologic Oncology
|
September 6, 2025
Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinoma
Natali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
Susan Halabi, Qian Yang, Akash Roy, et al.
European Urology Focus
|
March 11, 2023
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm
Stefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Cancers
|
April 14, 2025
Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in Quadragenarians
Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Maha Hussain, Claire Corcoran, Caroline Sibilla, et al.
European Urology
|
January 18, 2025
Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis
Silke Gillessen, Bertrand Tombal, Fabio Turco, et al.
JAMA Surgery
|
October 2, 2024
Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial
Rodney H Breau, Luke T Lavallée, Ilias Cagiannos, et al.
Page
of 100